Israeli-based digital health company UltraSight has received CE Mark for its new artificial intelligence (AI) guidance cardiac ultrasound software.
The new technology allows healthcare specialists to capture diagnostic quality ultrasound images of the heart.
By 2023, this is expected to increase detection of cardiovascular diseases (CVD) as well as patient access to cardiac imaging and optimised cardiac care across Europe.
